Oscotec Inc. (KOSDAQ:039200)

South Korea flag South Korea · Delayed Price · Currency is KRW
32,300
+1,550 (5.04%)
Jul 15, 2025, 3:30 PM KST
-26.00%
Market Cap 1.18T
Revenue (ttm) 34.88B
Net Income (ttm) 385.08M
Shares Out 38.25M
EPS (ttm) 9.98
PE Ratio 3,054.28
Forward PE 137.89
Dividend n/a
Ex-Dividend Date n/a
Volume 189,642
Average Volume 147,249
Open 30,900
Previous Close 30,750
Day's Range 30,750 - 32,550
52-Week Range 21,600 - 45,850
Beta 1.56
RSI 64.49
Earnings Date Aug 13, 2025

About Oscotec

Oscotec Inc. operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses. It develops SKI-O-703, a SYK inhibitor that is in Phase 2 clinical trials to treat rheumatoid arthritis and idiopathic thrombocytopenic purpura; SKI-G-801, a selective FLT3/AXL inhibitor, which is in Phase I clinical trial for the treatment of acute myeloid leukemia, as well as other solid tumors; and lazertinib, a 3rd generation EGFR inhibitor that is in Phase 3 clinical trials... [Read more]

Sector Healthcare
Founded 1998
Employees 51
Stock Exchange KOSDAQ
Ticker Symbol 039200
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.